BIOLASE, Inc.
BIOLQ
$0.0078
$0.00034.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 68.88% | 42.52% | -10.87% | 45.99% | 45.28% |
| Total Depreciation and Amortization | 15.18% | -54.35% | 342.95% | 419.53% | 359.02% |
| Total Amortization of Deferred Charges | -64.44% | -64.65% | 792.52% | -89.39% | 398.48% |
| Total Other Non-Cash Items | -462.17% | -1,643.08% | -27.89% | -52.65% | -88.27% |
| Change in Net Operating Assets | -435.98% | 547.47% | -110.28% | 3.84% | 235.42% |
| Cash from Operations | -72.80% | 79.39% | -4.95% | 59.10% | 60.46% |
| Capital Expenditure | 78.02% | 92.44% | -- | 60.72% | 93.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 118.68% | 116.81% | 133.56% | 99.36% | 93.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -98.00% | -67.22% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -91.71% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -100.00% | -- | -- | -- |
| Cash from Financing | -33.71% | -110.01% | -33.70% | 2,865.63% | 1,855.14% |
| Foreign Exchange rate Adjustments | 212.15% | -146.34% | -200.00% | -48.37% | 29.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -307.96% | -381.66% | -107.36% | 78.49% | 109.17% |
